Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-08-07

Clinical Trial Update: Recombinant BNP on Heart and Renal Function in Acute Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing recombinant B-type natriuretic peptide for effects on heart and renal function in acute heart failure (also considering …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Acute Heart Failure, Acute Renal Failure | Phase 2 | Status: UNKNOWN